147 related articles for article (PubMed ID: 38367145)
1. The relationship between advanced liver fibrosis and osteoporosis in type 2 diabetes patients with MAFLD.
Pan B; Zhao Y; Chen C; Cai J; Li K; Wang Y; Liu J
Endocrine; 2024 Feb; ():. PubMed ID: 38367145
[TBL] [Abstract][Full Text] [Related]
2. Associations of metabolic dysfunction-associated fatty liver disease and hepatic fibrosis with bone mineral density and risk of osteopenia/osteoporosis in T2DM patients.
Zhang W; Li Y; Li S; Zhou J; Wang K; Li Z; Chen N; Chen X
Front Endocrinol (Lausanne); 2023; 14():1278505. PubMed ID: 38116314
[TBL] [Abstract][Full Text] [Related]
3. Association between non-alcoholic fatty liver disease-associated hepatic fibrosis and bone mineral density in postmenopausal women with type 2 diabetes or impaired glucose regulation.
Zhu X; Yan H; Chang X; Xia M; Zhang L; Wang L; Sun X; Yang X; Gao X; Bian H
BMJ Open Diabetes Res Care; 2020 Aug; 8(1):. PubMed ID: 32759166
[TBL] [Abstract][Full Text] [Related]
4. Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies.
Zeng L; Li Y; Hong C; Wang J; Zhu H; Li Q; Cui H; Ma P; Li R; He J; Zhu H; Liu L; Xiao L
Osteoporos Int; 2024 Apr; 35(4):679-689. PubMed ID: 38221591
[TBL] [Abstract][Full Text] [Related]
5. Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults.
Li H; Luo H; Zhang Y; Liu L; Lin R
Front Endocrinol (Lausanne); 2022; 13():891382. PubMed ID: 35846319
[TBL] [Abstract][Full Text] [Related]
6. A Correlation Analysis Between Adult Hepatic Fibrosis and Bone Mineral Density of the Lumbar Spine and Hip.
Chen C; Zhang R; Ren C; Wang Y
Altern Ther Health Med; 2024 Jan; 30(1):172-178. PubMed ID: 37773670
[TBL] [Abstract][Full Text] [Related]
7. Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017-2018.
Liu J; Tang Y; Feng Z; Chen Y; Zhang X; Xia Y; Geng B
Osteoporos Int; 2023 Apr; 34(4):713-724. PubMed ID: 36719471
[TBL] [Abstract][Full Text] [Related]
8. [Associations between serum GDF15 and glycolipid metabolism disorder in metabolic associated fatty liver patients].
Li X; Yu XM; Li EH; Chen PH; Zheng LM; Zhang S
Zhonghua Nei Ke Za Zhi; 2023 Aug; 62(8):987-992. PubMed ID: 37528037
[No Abstract] [Full Text] [Related]
9. J-Shaped Relationship Between Serum Prolactin and Metabolic-Associated Fatty Liver Disease in Female Patients With Type 2 Diabetes.
Zhu C; Ma H; Huang D; Li G; Gao J; Cai M; You H; Bu L; Qu S
Front Endocrinol (Lausanne); 2022; 13():815995. PubMed ID: 35222274
[TBL] [Abstract][Full Text] [Related]
10. Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes.
Zhang X; Chen Y; Ye H; Luo Z; Li J; Chen Z; Zhang E; Li W
Endocrine; 2023 May; 80(2):366-379. PubMed ID: 36539681
[TBL] [Abstract][Full Text] [Related]
11. Serum Irisin is Associated with Bone Mineral Density in Postmenopausal T2dm Patients Complicated with Osteoporosis and in Mice with Diabetic Osteoporosis.
Hou X; Xing B; Zhang G; Wu H; Feng N; Li Y; Han G
Curr Protein Pept Sci; 2023; 24(4):355-363. PubMed ID: 36852814
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of non-alcoholic fatty liver disease fibrosis is closely associated with osteoporosis in women but not in men with type 2 diabetes.
Yu Z; Wu Y; Zhang R; Li Y; Zang S; Liu J
Endocr Connect; 2022 Nov; 11(11):. PubMed ID: 36129166
[TBL] [Abstract][Full Text] [Related]
13. Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis.
Muthiah M; Ng CH; Chan KE; Fu CE; Lim WH; Tan DJH; Nah B; Kong G; Xiao J; Yong JN; Tan B; Syn N; Wang JW; Sayed N; Tan E; Chew NW; Dan YY; Siddiqui MS; Sanyal AJ; Noureddin M
Ann Hepatol; 2023; 28(1):100762. PubMed ID: 36182031
[TBL] [Abstract][Full Text] [Related]
14. Low thyroid function is associated with an increased risk of advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease.
Fan H; Li L; Liu Z; Zhang P; Wu S; Han X; Chen X; Suo C; Cao L; Zhang T
BMC Gastroenterol; 2023 Jan; 23(1):3. PubMed ID: 36604612
[TBL] [Abstract][Full Text] [Related]
15. Effects of different nylestriol/levonorgestrel dosages on bone metabolism in female Sprague-Dawley rats with retinoic acid-induced osteoporosis.
Liao EY; Luo XH; Wang WB; Wu XP; Zhou HD; Dai RC; Liao HJ; Yang C
Endocr Res; 2003 Feb; 29(1):23-42. PubMed ID: 12665316
[TBL] [Abstract][Full Text] [Related]
16. Perirenal Fat Thickness is Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Type 2 Diabetes Mellitus.
Yang J; Li CW; Zhang JR; Qiu H; Guo XL; Wang W
Diabetes Metab Syndr Obes; 2023; 16():1953-1965. PubMed ID: 37405319
[TBL] [Abstract][Full Text] [Related]
17. The impact of concomitant hepatitis C virus infection on liver and cardiovascular risks in patients with metabolic-associated fatty liver disease.
Tsai PS; Cheng YM; Wang CC; Kao JH
Eur J Gastroenterol Hepatol; 2023 Nov; 35(11):1278-1283. PubMed ID: 37773778
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive screening, staging and management of metabolic dysfunction-associated fatty liver disease (MAFLD) in type 2 diabetes mellitus patients: what do we know so far ?
Binet Q; Loumaye A; Preumont V; Thissen JP; Hermans MP; Lanthier N
Acta Gastroenterol Belg; 2022; 85(2):346-357. PubMed ID: 35709779
[TBL] [Abstract][Full Text] [Related]
19. Age-related bone mineral density, osteoporosis rate and risk of vertebral fracture in mainland Chinese women with type 2 diabetes mellitus.
Shan PF; Wu XP; Zhang H; Cao XZ; Yuan LQ; Liao EY
J Endocrinol Invest; 2011 Mar; 34(3):190-6. PubMed ID: 20808073
[TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia as an independent risk factor for metabolic dysfunction-associated fatty liver disease in nonobese patients without type 2 diabetes mellitus.
Liu J; Wang C; Wang YT; Liu JX; Zhou TH; Yao SK; Chen G
Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E62-E71. PubMed ID: 37285598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
